cn
*The search scope is limited to the products of this site
Hebei Bayi Space Pharmaceutical Co., Ltd. (hereinafter referred to as "Hebei Bayi Space"), invested and founded by Beijing Bayi Space LCD technology Co., Ltd., was founded in July 2021, and its registered address is located in Lingang Economic and Technological Development Zone, Bohai new urban district, Cangzhou. It is mainly engaged in the R & D, production, sales, technical consultation and technical services of advanced pharmaceutical intermediates, chemical APIs, chemical products (excluding dangerous chemicals), chemical materials and plant extracts.
The company is located in the eastern area of Cangzhou Bohai New urban district Lingang Economic and Technological Development Zone. Cangzhou Bohai New urban district Lingang Economic and Technological Development Zone is the only "Beijing Cangzhou Bohai New urban district biomedical industrial park" in China that has implemented the extended supervision of drug production in different places so far, and the biomedical industry cluster created has initially taken shape. It lays a solid foundation for National Chemical Industry Park and later production.
The company's characteristic API and key pharmaceutical intermediates production and construction projects are designed in terms of construction, equipment and process in full accordance with the GMP production specifications of the United States, Europe and Japan and the strict EHS system. Through the production base construction project of characteristic APIs and key pharmaceutical intermediates, the company will further improve its quality system and standardized production management, help the company establish a good corporate image in the global market and enhance its competitiveness.
The existing products have broad market prospects and high technical and market barriers after repeated demonstration and judgment of the company. Advanced pharmaceutical intermediates mainly involve new psychiatric pharmaceutical intermediates and characteristic cardiovascular and cerebrovascular pharmaceutical intermediates, and the products have broad market prospects in Europe, America and China; Characteristic APIs mainly involve new contrast agents, and the technical level of related products has reached the leading level in the same industry, forming its own core competitiveness in terms of process routes and manufacturing costs.
Address: intersection of Tongsan road and Beifu Road, Lingang Economic and Technological Development Zone (East District), Cangzhou City, Hebei Province
Want to learn more about our business?
Contact our experts.
010-69765588
